Reports of Biochemistry
and Molecular Biology
Sat, Feb 7, 2026
[Archive]
Vol.14 No.2 Jul
Back to the articles list |
Back to browse issues page
Shaghayegh Tafazoli 
, Nazanin Akbari , Fatemeh Faravani , Jina KhayatZadeh * , Banafsheh Heidari , Maral Barzegar-Amini* , Seyed Reza Hosseini
, Nazanin Akbari , Fatemeh Faravani , Jina KhayatZadeh * , Banafsheh Heidari , Maral Barzegar-Amini* , Seyed Reza Hosseini
Department of Cellular and Molecular Biology, Islamic Azad University of Mashhad, Mashhad, Iran.
Abstract: (9 Views)
Background: Our study aims to assess how the combination of Ziziphora clinopodioides (Kakoti) extract and gamma radiation affects the survival of prostate cancer cells (DU-145) and normal kidney cells (HEK-293). In addition, the study seeks to investigate the potential protective effects of this extract against damage caused by radiation.
Methods: A Ziziphora extract was prepared using standard extraction techniques. The extract's effective dose for both cell lines was determined using the MTT assay. Three grays (Gy) of gamma radiation was used to simulate radiotherapy conditions. The impact of the extract alone, radiation alone, and their combination on cell viability was assessed. Data were analyzed using SPSS version 25 (IBM, USA), with significance set at P< 0.05.
Results: The extract significantly protected HEK-293 cells from radiation-induced damage at lower concentrations (P< 0.05), increasing cell viability by up to 20% compared to radiation alone. Conversely, it enhanced cytotoxicity in DU-145 cells, reducing viability by 30-50% at higher concentrations (P< 0.05). However, at higher radiation doses, the protective effect on normal cells diminished, with viability decreasing by 10-15%.
Conclusion: Ziziphora clinopodioides extract demonstrates dose-dependent potential as a protective agent for normal cells and a cytotoxic enhancer for prostate cancer cells under gamma radiation. These findings suggest that optimized dosing could be crucial for its clinical application in radiotherapy.
Methods: A Ziziphora extract was prepared using standard extraction techniques. The extract's effective dose for both cell lines was determined using the MTT assay. Three grays (Gy) of gamma radiation was used to simulate radiotherapy conditions. The impact of the extract alone, radiation alone, and their combination on cell viability was assessed. Data were analyzed using SPSS version 25 (IBM, USA), with significance set at P< 0.05.
Results: The extract significantly protected HEK-293 cells from radiation-induced damage at lower concentrations (P< 0.05), increasing cell viability by up to 20% compared to radiation alone. Conversely, it enhanced cytotoxicity in DU-145 cells, reducing viability by 30-50% at higher concentrations (P< 0.05). However, at higher radiation doses, the protective effect on normal cells diminished, with viability decreasing by 10-15%.
Conclusion: Ziziphora clinopodioides extract demonstrates dose-dependent potential as a protective agent for normal cells and a cytotoxic enhancer for prostate cancer cells under gamma radiation. These findings suggest that optimized dosing could be crucial for its clinical application in radiotherapy.
Keywords: Chemotherapy, Gamma Radiation, Oxidative Stress, Prostate Cancer, Radiotherapy, Ziziphora clinopodioides Extract.
Type of Article: Original Article |
Subject:
Cell Biology
Received: 2025/02/5 | Accepted: 2025/12/13
Received: 2025/02/5 | Accepted: 2025/12/13
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
